本发明涉及一种以阿奇霉素为主要成分的口服缓释干混悬剂。
The invention relates to oral sustained-release dry suspension taking azithromycin as a main ingredient.
它是以阿奇霉素为主要活性成分与药学上可接受的辅料通过制剂技术而制成的口服缓释干混悬剂。
The oral sustained-release dry suspension is prepared from the azithromycin serving as the main active ingredient and pharmaceutically acceptable supplementary materials by pharmaceutical technology.
它是以阿奇霉素为主要活性成分与药学上可接受的辅料通过制剂技术而制成的口服缓释干混悬剂。
The oral sustained-release dry suspension is prepared from the azithromycin serving as the main active ingredient and pharmaceutically acceptable supplementary materials by pharmaceutical technology.
应用推荐